Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00073671 · ClinicalTrials.gov registry record · NA

Prevention of Depression in At-Risk Adolescents

A NA study of Depression, sponsored by Vanderbilt University.

Completed
Registry status
NA
Development phase
316
Enrollment target
4
Study locations

NCT00073671 is a NA study of Depression that has completed, run by Vanderbilt University. The registered enrollment target is 316 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (60% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00073671, a NA study of Depression, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
NA
Development phase
316 participants
Enrollment target
4
Study locations

Study Summary

This study examines the impact of a group cognitive behavioral program aimed at preventing depressive disorders and symptoms in adolescents at risk for developing depression.

Conditions Studied

Interventions

  • OTHER Usual care
  • BEHAVIORAL Cognitive-behavioral prevention program

Study Locations (4)

Massachusetts

  • Harvard University Medical School - Boston

Oregon

  • Kaiser Permanente Center for Health Research - Portland

Pennsylvania

  • University of Pittsburgh Medical Center - Pittsburgh

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 316 participants
Start Date 2003-03
Est. Completion 2009-01
Phase NA

Sponsor

Vanderbilt University

430 total trials

What the Registry Record Tells You About NCT00073671

The ClinicalTrials.gov registry entry for NCT00073671 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 316 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (60% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.

NCT00073671 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Massachusetts, Oregon, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00073671 about?

NCT00073671 is a clinical study titled "Prevention of Depression in At-Risk Adolescents". This study examines the impact of a group cognitive behavioral program aimed at preventing depressive disorders and symptoms in adolescents at risk for developing depression.

What is the current status of trial NCT00073671?

This trial is currently completed. It is a NA study. The enrollment target is 316 participants. The study started on 2003-03. Estimated completion is 2009-01.

What conditions does trial NCT00073671 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT00073671?

The interventions under investigation include: Usual care (OTHER), Cognitive-behavioral prevention program (BEHAVIORAL).

Who is sponsoring clinical trial NCT00073671?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00073671 being conducted?

This trial has 4 study locations across Massachusetts, Oregon, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.